New Model for Eye Disease
New Model for Eye Disease
批准号:
6735560
负责人:
MARYANN L HALDI
金额:
$19.64万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2005-04-30
关键词:
angiogenesisangiographybiotechnologyblood vessel disorderconfocal scanning microscopydisease /disorder modelembryo /fetusembryogenesiseye circulationeye disordergene targetinggenetic translationgenetically modified animalshistologymodel design /developmentnonmammalian vertebrate embryologyoligonucleotidesretina disorderzebrafish
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Diseases of the retina, either genetically determined or secondary to systemic disease, are the leading cause of blindness in the industrialized world. More than 5.3 million Americans are affected by diabetic retinopathy. Another 1.6 million Americans over age 60 have age-related macular degeneration. Retinopathy of prematurity is a major cause of blindness in premature infants maintained by oxygen supplementation during the postnatal period. Using gene knockdown technology, this SBIR aims to validate the zebrafish embryo as a whole animal model for human eye diseases that result from vascular defects. This SBIR will characterize embryogenesis and patterning, and the formation of the vasculature of the zebrafish eye. Zebrafish is a good animal model for eye vascular disease. Orthologs of many genes involved in angiogenesis in mammals have been identified in zebrafish. Assays and drug treatment can easily be performed on the zebrafish embryo because of its rapid ex-utero development. Embryos are transparent, permitting visual observation of defects in development and angiogenesis in the eye and elsewhere. Furthermore, early stage embryos do not require blood for normal development, obtaining sufficient oxygen by diffusion. This permits performance of gene knockdown experiments, which would result in early lethality in mammalian models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Zebrafish Muscular Dystrophy Model for Drug Screening
-
批准号:7322088
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2007
-
负责人:MARYANN L HALDI
-
依托单位:
Brain Cancer Zebrafish Xenotransplant Model for Drug Screening
-
批准号:7110752
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2006
-
负责人:MARYANN L HALDI
-
依托单位:
Zebrafish Xenotransplant Model for Colorectal Cancer
-
批准号:6938199
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2005
-
负责人:MARYANN L HALDI
-
依托单位:
In Vivo Ocular Angiogenesis Assay
-
批准号:6876292
-
项目类别:
-
资助金额:$15.66万
-
财政年份:2005
-
负责人:MARYANN L HALDI
-
依托单位:
Zebrafish Screen for Ototoxic and Otoprotective Agents
-
批准号:7285590
-
项目类别:
-
资助金额:$40.69万
-
财政年份:2005
-
负责人:MARYANN L HALDI
-
依托单位:
Zebrafish Screen for Ototoxic and Otoprotective Agents
-
批准号:7489482
-
项目类别:
-
资助金额:$19.47万
-
财政年份:2005
-
负责人:MARYANN L HALDI
-
依托单位:
In Vivo Screen for Neuroprotective Agents
-
批准号:7671396
-
项目类别:
-
资助金额:$29.76万
-
财政年份:2004
-
负责人:MARYANN L HALDI
-
依托单位:
In Vivo Screen for Neuroprotective Agents
-
批准号:7848753
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2004
-
负责人:MARYANN L HALDI
-
依托单位:
In Vivo Screen for Neuroprotective Agents
-
批准号:7215383
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2004
-
负责人:MARYANN L HALDI
-
依托单位:
In Vivo Screen for Neuroprotective Agents
-
批准号:7473911
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2004
-
负责人:MARYANN L HALDI
-
依托单位:
海外基金